^
BIOMARKER:

FGFR1 expression

i
Other names: FGFR1, BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM, Fibroblast growth factor receptor 1
Entrez ID:
Phase 1
Maxinovel Pty., Ltd.
Recruiting
Last update posted :
05/11/2022
Initiation :
04/11/2022
Primary completion :
05/31/2023
Completion :
08/31/2023
FGFR1OP2
|
FGFR1 expression
|
Tuoyi (toripalimab) • Max-40279
Phase 1
Fundacion CRIS de Investigación para Vencer el ...
Recruiting
Last update posted :
02/09/2022
Initiation :
11/25/2020
Primary completion :
02/03/2023
Completion :
02/03/2023
HER-2 • FGFR1
|
HER-2 negative • FGFR1 expression
|
Ibrance (palbociclib) • fulvestrant • rogaratinib (BAY 1163877)
Phase 2
Swiss Group for Clinical Cancer Research
Active, not recruiting
Last update posted :
01/21/2022
Initiation :
07/25/2019
Primary completion :
12/01/2023
Completion :
12/01/2023
CD4
|
FGFR1 expression
|
rogaratinib (BAY 1163877)
Phase 2
Dana-Farber Cancer Institute
Withdrawn
Last update posted :
12/17/2019
Initiation :
11/27/2019
Primary completion :
11/27/2019
Completion :
11/27/2019
ALB
|
FGFR1 expression
|
rogaratinib (BAY 1163877)
Phase 1
GlaxoSmithKline
Completed
Last update posted :
08/19/2019
Initiation :
10/09/2013
Primary completion :
10/24/2017
Completion :
10/24/2017
FGF2
|
FGFR1 amplification • FGFR1 expression
|
cisplatin • carboplatin • paclitaxel • docetaxel • pemetrexed • FP-1039
Phase 1/2
Assistance Publique - Hôpitaux de Paris
Completed
Last update posted :
05/29/2019
Initiation :
09/01/2015
Primary completion :
09/01/2017
Completion :
10/01/2018
FGFR • TACC3 • TACC1
|
FGFR fusion • FGFR1 expression • FGFR1 fusion • FGFR3 fusion • TACC3 expression • FGFR3 expression • FGFR1-TACC1 fusion
|
ABSK091
Phase 1
Bayer
Completed
Last update posted :
04/18/2018
Initiation :
12/15/2015
Primary completion :
02/05/2017
Completion :
12/06/2017
FGFR1
|
FGFR3 mutation • FGFR1 expression • FGFR expression
|
rogaratinib (BAY 1163877)